Details of the Drug Pharmacogenomic Perturbation Atlas

General Information of Drug (ID: DM2EKX5)

• Drug Name: Antalarmin Drug Info
• Synonyms: Antalarmin; 157284-96-3; CHEMBL296641; 7H-Pyrrolo(2,3-d)pyrimidin-4-amine, N-butyl-N-ethyl-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)-; SCHEMBL466243; GTPL3489; AC1L433C; DTXSID50166241; CHEBI:139557; ZINC1539136; NSC715590; BDBM50074501; AKOS030559812; NSC-715590; NCGC00165732-01; NCI60_039940; LS-139513; N-butyl-N-ethyl-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[3,2-e]pyrimidin-4-amine; N-butyl-N-ethyl-7-mesityl-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
• Cross-matching ID:
  PubChem CID: 177990
  ChEBI ID: CHEMBL139557
  CAS Number: CAS 157284-96-3
  TTD Drug ID: D03KJS

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name	NES	FDR q-val	Tag %	Leading Edge Genes
Biosynthesis of unsaturated fatty acids	1.85	3.00e-2	21/27 (77.78%)	ELOVL2;ELOVL1;ACAA1;...

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone marrow

Neuroblastoma

Cell Line Name	Cellosaurus Accession	Species of Origin	Drug Dosage	Time Point	Details
SH-SY5Y	CVCL_0019	Homo sapiens	0.04uM - 10uM	24H	Hide ▲
SK-N-SH	CVCL_0531	Homo sapiens	0.04uM - 10uM	24H	Hide ▲